Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: 10K a day who wrote (696)	2/22/2000 10:10:00 PM
From: scott_jiminez	Read Replies (1) \| Respond to of 52153

Anyone have any ideas for 'hospital safety' investments in light of the 'anti-mistake' initiative in the news today. The two that I find most interesting are Immucor (BLUD) and Univec (UNVC). The former tests blood and has decently solid financials while the latter sells single-use, auto-destruct syringes and has non-decent financials (but has won two contracts within the last week). Oh yeah, impristine: the average loss of the 8 genomics companies you noted was ~8.5%. ARIA, which is a contested member of that group (but has gained MORE than any one of them since October - ~2000%), was down also. By 2.2%.